Clinical Trial Update: Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating add-on SGLT2 inhibitors, thiazolidinediones, or their combination in adults with type 2 diabetes mellitus who are already on a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor
• SGLT2 inhibitor
• Thiazolidinedione (thiazolidinedione)

Snippet

Sponsor: Yonsei University | Conditions: Diabetes Mellitus, Type 2, Hyperglycemia | Phase 4 | Status: NOT_YET_RECRUITING